ConductScience.org, home

Paper14769732

Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial.

Moss RB and 11 others. Chest, 2004. Cited by 294 papers, by iCite.

Cite this record

ConductScience Library. Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial. Papers, record 14769732. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14769732

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial.
PubMed
Journal
Chest
PubMed
Year
2004
PubMed
Publication types
Clinical Trial, Clinical Trial, Phase II, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial
PubMed
Citations, by iCite
294
iCite
Relative citation ratio, by iCite
6.51
iCite
Revised in PubMed
2019-05-14
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Moss RBRichard B
2Rodman DDavid
3Spencer LTL Terry
4Aitken MLMoira L
5Zeitlin PLPamela L
6Waltz DDavid
7Milla CCarlos
8Brody ASAlan S
9Clancy JPJohn P
10Ramsey BBonnie
11Hamblett NNicole
12Heald AEAlison E

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cystic FibrosisMajor topic
Cystic Fibrosis Transmembrane Conductance RegulatorMajor topic
Genetic TherapyMajor topic
Administration, Inhalation
Adolescent
Adult
Aerosols
Analysis of Variance
Bronchoscopy
Child
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Female
Gene Transfer Techniques
Humans
Male
Probability
Respiratory Function Tests
Risk Assessment
Severity of Illness Index
Statistics, Nonparametric
Treatment Outcome

Source PubMed

Download CSV of topics

Cited by139

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 294 citations.

PMIDTitleJournalYearIn PapersSource
42654157Combining Gene Therapy with Current Modulator Treatments for Cystic Fibrosis: A Promising Area of Research.Pharmaceutics2026https://conductscience.org/library/papers/42654157PubMed
42376650CFTR gene delivery to human airway epithelia using parainfluenza virus 5 amplifying virus-like particles.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/42376650PubMed
42278347Safety of Adeno-Associated Viral Vectors in Gene Therapy: Mechanisms of Toxicity, Clinical Risks, and Strategies for Their Minimization.Int J Mol Sci2026https://conductscience.org/library/papers/42278347PubMed
42182483Optimized AAV capsids robustly transduce airway epithelial cells.bioRxiv2026https://conductscience.org/library/papers/42182483PubMed
41977378Immune Toxicities in AAV Gene Therapy: Overview for Clinicians.Int J Mol Sci2026https://conductscience.org/library/papers/41977378PubMed
41866915Inhalable gene and RNA therapy for cystic fibrosis: perspectives and progress in clinical development.Nanomedicine (Lond)2026https://conductscience.org/library/papers/41866915PubMed
41789512Autocrine SFRP2 (secreted frizzled related protein 2) enhances lung myofibroblast fibrogenic activity by suppressing PINK1-mediated mitophagy initiation.Autophagy2026https://conductscience.org/library/papers/41789512PubMed
41613863Genetically engineered approaches to the treatment of cystic fibrosis.Biophys Rev2025https://conductscience.org/library/papers/41613863PubMed
40752498Maximising opportunity for therapeutic success: sequential participation in cystic fibrosis nucleic acid-based therapy trials.Lancet Respir Med2025https://conductscience.org/library/papers/40752498PubMed
40665138Advances and Challenges in Adeno-Associated Virus Gene Therapy Applications of Localized Delivery Strategies.Curr Med Sci2025https://conductscience.org/library/papers/40665138PubMed
40430940Generation and Treatment of a Novel Severe Model of Visceral Gaucher Disease by Genetic Therapy.Pharmaceutics2025https://conductscience.org/library/papers/40430940PubMed
40380180Inhibition of DLK1 regulates AT2 differentiation and alleviates established pulmonary fibrosis by upregulating TTF-1/CLDN6.Respir Res2025https://conductscience.org/library/papers/40380180PubMed
40006994Adeno-Associated Virus Vectors: Principles, Practices, and Prospects in Gene Therapy.Viruses2025https://conductscience.org/library/papers/40006994PubMed
39583120Mechanism of Genome Editing Tools and Their Application on Genetic Inheritance Disorders.Glob Med Genet2024https://conductscience.org/library/papers/39583120PubMed
39225214Recent Advances in Therapeutics and Manufacturing Processes of Recombinant Adeno-Associated Virus for the Treatment of Lung Diseases.Curr Gene Ther2025https://conductscience.org/library/papers/39225214PubMed
39199292Aerosol Inhalation of Gene Delivery Therapy for Pulmonary Diseases.Biomolecules2024https://conductscience.org/library/papers/39199292PubMed
39069560Amelioration of airway and GI disease in G551D-CF ferrets by AAV1 and AAV6.Gene Ther2024https://conductscience.org/library/papers/39069560PubMed
38323309Understanding AAV vector immunogenicity: from particle to patient.Theranostics2024https://conductscience.org/library/papers/38323309PubMed
38247731Gene Therapy for Genetic Syndromes: Understanding the Current State to Guide Future Care.BioTech (Basel)2024https://conductscience.org/library/papers/38247731PubMed
38077224Reciprocal mutations of lung-tropic AAV capsids lead to improved transduction properties.Front Genome Ed2023https://conductscience.org/library/papers/38077224PubMed

See all 139 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CFTR1080PubTator's text mininghttps://conductscience.org/library/genes/1080NCBI Gene
CXCL83576PubTator's text mininghttps://conductscience.org/library/genes/3576NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14769732

GET https://conductscience.org/api/papers/v1/14769732/cited_by?page=2